Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
8
×
Tags
biotech
biotech ipos
8
×
clinical trials
life sciences
national blog main
boston blog main
boston top stories
san francisco blog main
san francisco top stories
national top stories
new york blog main
new york top stories
fda
investing
national
pfizer
cancer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer immunotherapy
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
medicare
nonalcoholic steatohepatitis
roche
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
vertex pharmaceuticals
wisconsin blog main
What
ipo
bio
biotech
drug
life
research
roundup
science
week
brings
companies
company
days
developing
ipos
market
medicines
new
public
raised
street
wall
way
welcomed
advantages
alliance
alzheimer’s
annual
arrival
assessed
attention
bar
biotechs
blood
boost
bristol
broader
buy
calls
cancer
Language
unset
Current search:
photo
×
" biotech ipos "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More